Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease.

BACKGROUND & AIMS There have been few studies of the role of de novo lipogenesis in the development of nonalcoholic fatty liver disease (NAFLD). We used isotope analyses to compare de novo lipogenesis and fatty acid flux between subjects with NAFLD and those without, matched for metabolic factors (controls). METHODS We studied subjects with metabolic syndrome and/or levels of alanine aminotransferase and aspartate aminotransferase >30 mU/L, using magnetic resonance spectroscopy to identify those with high levels (HighLF, n = 13) or low levels (LowLF, n = 11) of liver fat. Clinical and demographic information was collected from all participants, and insulin sensitivity was measured using the insulin-modified intravenous glucose tolerance test. Stable isotopes were administered and gas chromatography with mass spectrometry was used to analyze free (nonesterified) fatty acid (FFA) and triacylglycerol flux and lipogenesis. RESULTS Subjects with HighLF (18.4% ± 3.6%) had higher plasma levels of FFAs during the nighttime and higher concentrations of insulin than subjects with LowLF (3.1% ± 2.7%; P = .04 and P < .001, respectively). No differences were observed between groups in adipose flux of FFAs (414 ± 195 μmol/min for HighLF vs 358 ± 105 μmol/min for LowLF; P = .41) or production of very-low-density lipoprotein triacylglycerol from FFAs (4.06 ± 2.57 μmol/min vs 4.34 ± 1.82 μmol/min; P = .77). In contrast, subjects with HighLF had more than 3-fold higher rates of de novo fatty acid synthesis than subjects with LowLF (2.57 ± 1.53 μmol/min vs 0.78 ± 0.42 μmol/min; P = .001). As a percentage of triacylglycerol palmitate, de novo lipogenesis was 2-fold higher in subjects with HighLF (23.2% ± 7.9% vs 10.1% ± 6.7%; P < .001); this level was independently associated with the level of intrahepatic triacylglycerol (r = 0.53; P = .007). CONCLUSIONS By administering isotopes to subjects with NAFLD and control subjects, we confirmed that those with NAFLD have increased synthesis of fatty acids. Subjects with NAFLD also had higher nocturnal plasma levels of FFAs and did not suppress the contribution from de novo lipogenesis on fasting. These findings indicate that lipogenesis might be a therapeutic target for NAFLD.

[1]  G. Ball,et al.  A meal high in saturated fat evokes postprandial dyslipemia, hyperinsulinemia, and altered lipoprotein expression in obese children with and without nonalcoholic fatty liver disease. , 2013, JPEN. Journal of parenteral and enteral nutrition.

[2]  M. Jensen,et al.  Systemic Free Fatty Acid Disposal Into Very Low-Density Lipoprotein Triglycerides , 2013, Diabetes.

[3]  N. Lundbom,et al.  Effect of short-term carbohydrate overfeeding and long-term weight loss on liver fat in overweight humans. , 2012, The American journal of clinical nutrition.

[4]  N. Chalasani,et al.  Nonalcoholic fatty liver disease (NAFLD): Is it really a serious condition? , 2012, Hepatology.

[5]  J. Miles,et al.  Effect of insulin infusion on spillover of meal-derived fatty acids. , 2012, The Journal of clinical endocrinology and metabolism.

[6]  R. Phair,et al.  Insulin Activation of Plasma Nonesterified Fatty Acid Uptake in Metabolic Syndrome , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[7]  J. Hardies,et al.  Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease , 2012, Hepatology.

[8]  J. Hardies,et al.  Prevalence of Prediabetes and Diabetes and Metabolic Profile of Patients With Nonalcoholic Fatty Liver Disease (NAFLD) , 2012, Diabetes Care.

[9]  J. Browning,et al.  Excessive hepatic mitochondrial TCA cycle and gluconeogenesis in humans with nonalcoholic fatty liver disease. , 2011, Cell metabolism.

[10]  J. Heimbach,et al.  Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States. , 2011, Gastroenterology.

[11]  Scott E. Crouter,et al.  Validity of the Actical for estimating free-living physical activity , 2011, European Journal of Applied Physiology.

[12]  J. Schulz-Menger,et al.  Randomized comparison of reduced fat and reduced carbohydrate hypocaloric diets on intrahepatic fat in overweight and obese human subjects , 2011, Hepatology.

[13]  G. Farrell,et al.  Postprandial hyperinsulinemia is universal in non‐diabetic patients with nonalcoholic fatty liver disease , 2011, Journal of gastroenterology and hepatology.

[14]  G. Farrell.  PNPLeAse get the fats right: Does lipogenesis or lipolysis cause NASH? 1 , 2010, Hepatology.

[15]  R. DeFronzo,et al.  ORIGINAL ARTICLE: Pioglitazone improvement of fasting and postprandial hyperglycaemia in Mexican‐American patients with Type 2 diabetes: a double tracer OGTT study , 2010, Clinical endocrinology.

[16]  Shijie Li,et al.  Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis , 2010, Proceedings of the National Academy of Sciences.

[17]  E. Schleicher,et al.  Hepatic lipid composition and stearoyl-coenzyme A desaturase 1 mRNA expression can be estimated from plasma VLDL fatty acid ratios. , 2009, Clinical chemistry.

[18]  E. Ryan,et al.  Synthesis of specific fatty acids contributes to VLDL-triacylglycerol composition in humans with and without type 2 diabetes , 2009, Diabetologia.

[19]  S. Klein,et al.  Dietary fat and carbohydrates differentially alter insulin sensitivity during caloric restriction. , 2009, Gastroenterology.

[20]  Wei Zhang,et al.  Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. , 2009, The Journal of clinical investigation.

[21]  E. Parks,et al.  Dietary sugars stimulate fatty acid synthesis in adults. , 2008, The Journal of nutrition.

[22]  B. S. Mohammed,et al.  Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects. , 2008, Gastroenterology.

[23]  F. Karpe,et al.  Reduced oxidation of dietary fat after a short term high-carbohydrate diet. , 2008, The American journal of clinical nutrition.

[24]  B. S. Mohammed,et al.  Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease. , 2008, Gastroenterology.

[25]  N. Lundbom,et al.  Postprandial lipemia associates with liver fat content. , 2007, The Journal of clinical endocrinology and metabolism.

[26]  X. Papademetris,et al.  The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome , 2007, Proceedings of the National Academy of Sciences.

[27]  M. Chong,et al.  Mechanisms for the acute effect of fructose on postprandial lipemia. , 2007, The American journal of clinical nutrition.

[28]  K. Petersen,et al.  Disordered lipid metabolism and the pathogenesis of insulin resistance. , 2007, Physiological reviews.

[29]  R. Neese,et al.  Delayed secretory pathway contributions to VLDL-triglycerides from plasma NEFA, diet, and de novo lipogenesis in humans Published, JLR Papers in Press, August 23, 2006. , 2006, Journal of Lipid Research.

[30]  Dong Wang,et al.  Saturated fatty acids induce endoplasmic reticulum stress and apoptosis independently of ceramide in liver cells. , 2006, American journal of physiology. Endocrinology and metabolism.

[31]  I. Goldberg,et al.  Ins and outs modulating hepatic triglyceride and development of nonalcoholic fatty liver disease. , 2006, Gastroenterology.

[32]  E. Murphy,et al.  Stable isotope methods for the in vivo measurement of lipogenesis and triglyceride metabolism. , 2006, Journal of animal science.

[33]  E. Parks,et al.  Contributions of different fatty acid sources to very low-density lipoprotein-triacylglycerol in the fasted and fed states. , 2006, The Journal of clinical endocrinology and metabolism.

[34]  R. Krauss,et al.  Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement , 2005, Current opinion in cardiology.

[35]  E. Parks,et al.  Increased dietary substrate delivery alters hepatic fatty acid recycling in healthy men. , 2005, Diabetes.

[36]  J. Jessurun,et al.  Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. , 2005, The Journal of clinical investigation.

[37]  D. Cook,et al.  Real-time assessment of postprandial fat storage in liver and skeletal muscle in health and type 2 diabetes. , 2005, American journal of physiology. Endocrinology and metabolism.

[38]  Jonathan C. Cohen,et al.  Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity , 2004, Hepatology.

[39]  P. Iozzo,et al.  Defective liver disposal of free fatty acids in patients with impaired glucose tolerance. , 2004, The Journal of clinical endocrinology and metabolism.

[40]  M. Beylot,et al.  Contribution of hepatic de novo lipogenesis and reesterification of plasma non esterified fatty acids to plasma triglyceride synthesis during non-alcoholic fatty liver disease. , 2003, Diabetes & metabolism.

[41]  S. Turner,et al.  Measurement of TG synthesis and turnover in vivo by 2H2O incorporation into the glycerol moiety and application of MIDA. , 2003, American journal of physiology. Endocrinology and metabolism.

[42]  Robert V Farese,et al.  Triglyceride accumulation protects against fatty acid-induced lipotoxicity , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[43]  G. Marchesini,et al.  Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. , 2001, Diabetes.

[44]  J. Clore,et al.  Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. , 2001, Gastroenterology.

[45]  J. Martínez,et al.  Postprandial de novo lipogenesis and metabolic changes induced by a high-carbohydrate, low-fat meal in lean and overweight men. , 2001, The American journal of clinical nutrition.

[46]  M. Hellerstein,et al.  Relationship between carbohydrate-induced hypertriglyceridemia and fatty acid synthesis in lean and obese subjects. , 2000, Journal of lipid research.

[47]  R. Krauss,et al.  Effects of a low-fat, high-carbohydrate diet on VLDL-triglyceride assembly, production, and clearance. , 1999, The Journal of clinical investigation.

[48]  M. Hellerstein.  De novo lipogenesis in humans: metabolic and regulatory aspects , 1999, European Journal of Clinical Nutrition.

[49]  G. Boden,et al.  The effects of free fatty acids on gluconeogenesis and glycogenolysis in normal subjects. , 1999, The Journal of clinical investigation.

[50]  E. Parks,et al.  VLDL-triglyceride production after alcohol ingestion, studied using [2-13C1] glycerol. , 1998, Journal of lipid research.

[51]  J. Hirsch,et al.  Human fatty acid synthesis is reduced after the substitution of dietary starch for sugar. , 1998, The American journal of clinical nutrition.

[52]  B. Patterson.  Use of stable isotopically labeled tracers for studies of metabolic kinetics: an overview. , 1997, Metabolism: clinical and experimental.

[53]  R. Hammer,et al.  Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-1a. , 1996, The Journal of clinical investigation.

[54]  S. Turner,et al.  Short-term alterations in carbohydrate energy intake in humans. Striking effects on hepatic glucose production, de novo lipogenesis, lipolysis, and whole-body fuel selection. , 1995, The Journal of clinical investigation.

[55]  R. Havel,et al.  Relationships between the responses of triglyceride-rich lipoproteins in blood plasma containing apolipoproteins B-48 and B-100 to a fat-containing meal in normolipidemic humans. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[56]  E. Parks,et al.  Temporal pattern of de novo lipogenesis in the postprandial state in healthy men. , 2005, The American journal of clinical nutrition.

[57]  J. Schwarz,et al.  Hepatic de novo lipogenesis in normoinsulinemic and hyperinsulinemic subjects consuming high-fat, low-carbohydrate and low-fat, high-carbohydrate isoenergetic diets. , 2003, The American journal of clinical nutrition.

[58]  J. McGarry.  Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. , 2002, Diabetes.